CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome: While LBC is typically estrogen receptor-positive and historically considered to have a favorable prognosis, emerging molecular evidence suggests that CDH1 loss contributes to distinct clinical behavior.